Pharma Journalist -

Galapagos NV and Fibrocor Therapeutics Inc. announced an expanded collaboration focused on novel targets in fibrosis, with Galapagos taking an equity stake in Fibrocor. Fibrocor is a…
Read More...

Clovis Oncology announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s supplemental New Drug Application (sNDA) for Rubraca (rucaparib) and granted…
Read More...

Dermavant Sciences, a dermatology-focused subsidiary of Roivant Sciences, announced that it has entered into a collaboration and license agreement with Japan Tobacco Inc. (JT) for…
Read More...

ASC Therapeutics announced that it has entered into a long-term strategic manufacturing partnership with Vigene Biosciences, a Maryland-based Contract Develop and Manufacturing…
Read More...

ProBioGen AG and Lava Therapeutics B.V. announced the closing of a cell line development and manufacturing agreement for Lava’s novel bispecific antibody lead candidate. Founded in…
Read More...

My Green Lab announced a collaboration with AstraZeneca to implement a global-scale green labs program across their research sites as part of their commitment to sustainability,…
Read More...

Astellas Pharma Inc., through its wholly-owned subsidiary Universal Cells, Inc, and Adaptimmune Therapeutics plc, a leader in cell therapy to treat cancer, announced that they have…
Read More...

MorphoSys AG and Incyte Corporation announced that the companies have entered into a collaboration and license agreement to further develop and commercialize MorphoSys' proprietary…
Read More...

SMi has released an exclusive interview with industry expert Martin Slegl, Regional Principal of East Europe, IQVIA, ahead of the upcoming Parallel Trade conference this February.  …
Read More...

SMi Reports: Industry expert and conference speaker, Robert Young, Principal, Blue Burgundy, was interviewed ahead of March’s AI in Drug Discovery conference. SMi Group’s inaugural…
Read More...